Dr Liza Raymond

Dual PD-1 and CTLA-4 checkpoint blockade promotes antitumor immune responses through CD4+Foxp3- cell-mediated modulation of CD103+ dendritic cells

Paul Beavis, Melissa Henderson, Lauren Giuffrida, Alexander Davenport, Emma Petley, Imran House, Junyun Lai, Kevin Sek, Nicole Milenkovski, Liza John, Sherly Mardiana, Clare Slaney, Joseph Trapani, Sherene Loi, Michael Kershaw, Nicole Haynes, Phillip Darcy

(2018), Vol. 6, pp. 1069-1081, Cancer immunology research, Philadelphia, Pa., C1

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul Beavis, Melissa Henderson, Lauren Giuffrida, Jane Mills, Kevin Sek, Ryan Cross, Alexander Davenport, Liza John, Sherly Mardiana, Clare Slaney, Ricky Johnstone, Joseph Trapani, John Stagg, Sherene Loi, Lev Kats, David Gyorki, Michael Kershaw, Phillip Darcy

(2017), Vol. 127, pp. 929-941, Journal of clinical investigation, New York, N.Y., C1

A multifunctional role for adjuvant Anti-4-1BB therapy in augmenting antitumor response by chimeric antigen receptor T cells

Sherly Mardiana, Liza John, Melissa Henderson, Clare Slaney, Bianca von Scheidt, Lauren Giuffrida, Alexander Davenport, Joseph Trapani, Paul Neeson, Sherene Loi, Nicole Haynes, Michael Kershaw, Paul Beavis, Phillip Darcy

(2017), Vol. 77, pp. 1296-1309, Cancer research, Philadelphia, Pa., C1

The double‐edged sword of IFN‐γ‐dependent immune‐based therapies

Liza John, Phillip Darcy

(2016), Vol. 94, pp. 527-528, Immunology & cell biology, Chichester, Eng., C1

A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer

Carmen Yong, Liza John, Christel Devaud, Miles Prince, Ricky Johnstone, Joseph Trapani, Phillip Darcy, Michael Kershaw

(2016), Vol. 7, pp. 34582-34598, Oncotarget, Albany, N.Y., C1

Adenosine receptor 2A blockade increases the efficacy of Anti-PD-1 through enhanced Antitumor T-cell responses

Paul Beavis, Nicole Milenkovski, Melissa Henderson, Liza John, Bertrand Allard, Sherene Loi, Michael Kershaw, John Stagg, Phillip Darcy

(2015), Vol. 3, pp. 506-517, Cancer immunology research, Philadelphia, Pa., C1

Cross-talk between tumors can affect responses to therapy

C Devaud, L Raymond, J Westwood, C Yong, P Beavis, R Schwendener, P Darcy, M Kershaw

(2015), Vol. 4, pp. 1-12, OncoImmunology, London, Eng., C1

Foxp3 expression in macrophages associated with RENCA tumors in mice

C Devaud, C Yong, L John, J Westwood, C Duong, C House, D Denoyer, J Li, P Darcy, M Kershaw

(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, Calif., C1-1

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors

C Devaud, J Westwood, M Teng, L Raymond, C Yong, C Duong, M Smyth, P Darcy, M Kershaw

(2014), Vol. 3, pp. e963395-1-e963395-10, OncoImmunology, London, Eng., C1-1

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy

C Devaud, J Westwood, L Raymond, J Flynn, S Paquet-Fifield, C Duong, C Yong, H Pegram, S Stacker, M Achen, T Stewart, L Snyder, M Teng, M Smyth, P Darcy, M Kershaw

(2014), Vol. 22, pp. 18-27, Molecular Therapy, Amsterdam, The Netherlands, C1-1

Pegasus, the 'atypical' Ikaros family member, influences left-right asymmetry and regulates pitx2 expression

L John, M Trengove, F Fraser, S Yoong, A Ward

(2013), Vol. 377, pp. 46-54, Developmental Biology, Maryland Heights, Mo., C1

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

Paul Beavis, Upulie Divisekera, Christophe Paget, Melvyn Chow, Liza John, Christel Devaud, Karen Dwyer, John Stagg, Mark Smyth, Phillip Darcy

(2013), Vol. 110, pp. 14711-14716, Proceedings of the National Academy of Sciences of the United States of America, Washington, D.C., C1

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

Liza Raymond, Michael Kershaw, Phillip Darcy

(2013), Vol. 2, pp. e26286-1-e26286-3, OncoImmunology, London, Eng., C1-1

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

M Kershaw, C Devaud, L Raymond, J Westwood, P Darcy

(2013), Vol. 2, pp. e25962-1-e25962-6, OncoImmunology, London, Eng., C1-1

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

C Devaud, L Raymond, J Westwood, P Darcy, M Kershaw

(2013), Vol. 2, pp. e25961-1-e25961-9, OncoImmunology, London, Eng., C1-1

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells

L Raymond, C Devaud, C Duong, C Yong, P Beavis, N Haynes, M Chow, M Smyth, M Kershaw, P Darcy

(2013), Vol. 19, pp. 5636-5646, Clinical Cancer Research, Philadelphia, Pa., C1-1

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

M Henderson, C Yong, C Duong, A Davenport, Liza John, C Devaud, P Neeson, J Westwood, P Darcy, M Kershaw

(2013), Vol. 5, pp. 577-590, Immunotherapy, London, Eng., C1-1

Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach

C Duong, J Westwood, C Yong, A Murphy, C Devaud, L Raymond, P Darcy, M Kershaw

(2013), Vol. 8, PLoS One, San Francisco, Calif., C1-1

Using electroporation to determine function of a chimeric antigen receptor in T cell and macrophage cell lines

C Yong, C Duong, C Devaud, L John, P Darcy, M Kershaw

(2013), Vol. 5, pp. 1-11, Open Gene Therapy Journal, C1

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

J Quetglas, L Raymond, M Kershaw, L Álvarez-Vallina, I Melero, P Darcy, C Smerdou

(2012), Vol. 1, pp. 1344-1354, OncoImmunology, London, Eng., C1-1

Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer

L Raymond, L Howland, J Flynn, A West, C Devaud, C Duong, T Stewart, J Westwood, Z Guo, D Bartlett, M Smyth, M Kershaw, P Darcy

(2012), Vol. 72, pp. 1651-1660, Cancer Research, Philadelphia, Pa., C1-1

The Ikaros gene family : transcriptional regulators of hematopoiesis and immunity

L John, A Ward

(2011), Vol. 48, pp. 1272-1278, Molecular immunology, Oxford, U. K., C1

Origins of adaptive immunity

C Liongue, L John, A Ward

(2011), Vol. 31, pp. 61-71, Critical reviews in immunology, Redding, Conn., C1

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

Sally Amos, Hollie Pegram, Jennifer Westwood, Liza Raymond, Christel Devaud, Chris Clarke, Nicholas Restifo, Mark Smyth, Phillip Darcy, Michael Kershaw

(2011), Vol. 60, pp. 671-683, Cancer immunology, immunotherapy, Cham, Switzerland, C1-1

Evolution of the ikaros gene family : implications for the origins of adaptive immunity

L John, S Yoong, A Ward

(2009), Vol. 182, pp. 4792-4799, The journal of immunology, Bethesda, Md., C1